Efficacy and cost-effectiveness of cell saver usage in the repair of thoracic aortic aneurysms and dissections

Simple item page
dc.contributor.authorAmanvermez Senarslan D.
dc.contributor.authorYildirim F.
dc.contributor.authorKurdal A.T.
dc.contributor.authorDamar A.
dc.contributor.authorOzturk T.
dc.contributor.authorTetik O.
dc.date.accessioned2024-07-22T08:04:02Z
dc.date.available2024-07-22T08:04:02Z
dc.date.issued2022
dc.description.abstractIntroduction: A substantial amount of blood loss occurs during the open repair of aortic aneurysms or dissections. The aim of the present study is to determine the efficacy and cost-effectiveness of cell saver devices in blood conservation during the open repair of thoracic aortic pathologies. Methods: The present study prospectively collected the data pertaining to 25 patients who underwent surgical management of thoracic aortic aneurysms or dissections using a cell saver (Group 1, n = 25). The volume and cost of transfusion and postoperative outcomes were compared with the second group of patients who underwent surgery without the use of cell savers in the previous year (Group 2, n = 25); the data pertaining to the same were retrospectively collected from the hospital records. The patient characteristics and categorical variables were compared using the x2 test and Fisher’s exact test. Transfusion volume and costs were compared using the independent samples t-test and Mann–Whitney U test. Results: The patients in both the groups displayed similar characteristics and risk factors. The total volume of allogenic red blood cell (p < 0.001) and total blood product (p = 0.01) transfusions were significantly lower in Group 1. The cost of red blood cell (p < 0.001) and total transfusions (p = 0.03) were lower in Group 1. The two groups displayed similar in-hospital morbidity and mortality rates. Conclusions: There was a significant association between the use of cell savers and the decreased need for red blood cell and total blood product transfusions. Considering the cost of the cell saver set, transfusion costs in the two groups were comparable. © The Author(s) 2021.
dc.identifier.DOI-ID10.1177/02676591211028178
dc.identifier.issn02676591
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12545
dc.language.isoEnglish
dc.publisherSAGE Publications Ltd
dc.subjectAortic Aneurysm, Thoracic
dc.subjectBlood Transfusion
dc.subjectBlood Transfusion, Autologous
dc.subjectCost-Benefit Analysis
dc.subjectHumans
dc.subjectRetrospective Studies
dc.subjectTreatment Outcome
dc.subjectadult
dc.subjectArticle
dc.subjectblood autotransfusion
dc.subjectblood conservation
dc.subjectblood volume
dc.subjectclinical article
dc.subjectclinical outcome
dc.subjectcontrolled study
dc.subjectcost effectiveness analysis
dc.subjectdissecting aortic aneurysm
dc.subjectdissection
dc.subjectendovascular aneurysm repair
dc.subjecterythrocyte volume
dc.subjectfemale
dc.subjectFisher exact test
dc.subjecthealth care cost
dc.subjecthospitalization
dc.subjecthuman
dc.subjecthuman cell
dc.subjectin-hospital mortality
dc.subjectintensive care unit
dc.subjectlength of stay
dc.subjectmale
dc.subjectmedical record
dc.subjectmiddle aged
dc.subjectmorbidity
dc.subjectmortality rate
dc.subjectopen surgery
dc.subjectprospective study
dc.subjectrank sum test
dc.subjectretrospective study
dc.subjectrisk factor
dc.subjectthoracic aorta aneurysm
dc.subjectblood transfusion
dc.subjectcost benefit analysis
dc.subjecttreatment outcome
dc.titleEfficacy and cost-effectiveness of cell saver usage in the repair of thoracic aortic aneurysms and dissections
dc.typeArticle

Files

Collections

Scopus Koleksiyonu